We describe a case of a woman with cholangiocarcinoma with transheterozygous BRCA1 and BRCA2 co-mutations who failed initial chemotherapy and was treated with targeted therapy for BRCA-positive patients. The gene discussed is BRCA1; the disease is cholangiocarcinoma.